Survivor Profile: Tricia Riffenburgh, Stage IV Melanoma
…Stage IV melanoma in numerous areas of her body, predominately in her brain. Tricia couldn’t believe the news. She was…
Survivor Profile: Tricia Riffenburgh, Stage IV Melanoma
…Stage IV melanoma in numerous areas of her body, predominately in her brain. Tricia couldn’t believe the news. She was…
The FDA Approval of TIL Therapy and What it Means for Advanced Melanoma
…melanoma cells. In this webinar, hosted by Samantha Guild, JD, President of AIM at Melanoma, we explore the implications of…
,
,
Elizabeth’s Battle Against Melanoma: How Clinical Trials Changed Her Life
By Mara Klecker Elizabeth Rounseville hardly knew what melanoma was when she was diagnosed in 2018 after going to see…
,
From Tanning Beds to Sun Safety: Brittanny Groover’s Journey of Melanoma Awareness and Advocacy
…a raw and honest portrayal of living with melanoma. The posts helped her connect with other melanoma patients and survivors…
,
New Therapies Under Investigation for Patients With Metastatic Uveal Melanoma
Results from a Phase 2 clinical trial for patients with advanced uveal melanoma were presented at ESMO 2024 on September…
,
Surviving & Thriving: From Melanoma Survivor to Sun Safety Advocate
…programs and supporting families through tough times. After retiring from Hospice of the Valley, Ann turned her focus to preventing…
,
Hope on the Horizon: Clinical Trials & Progress in Ocular/Uveal Melanoma
AIM at Melanoma, in collaboration with its Canadian partner, the Save Your Skin Foundation, is pleased to present this informative…
Melanoma Monday: Every Day. Everywhere.
May is Melanoma Awareness Month—but melanoma doesn’t follow a calendar. It doesn’t wait for summer vacations or long afternoons at…
In Plain English… The Excitement Surrounding Opdivo
…clinical trial to improve overall survival in patients with metastatic melanoma, and it ushered in the era of immunotherapy. Because…
,
Donor Spotlight: Gina Roller
Friendship is Forever By Mara Klecker Gina Roller’s best friend, Kerri-Lynn Larimer, adopted and lived by the motto “crazy not…
,
,
Recent Posts
Jun. 09, 2026
The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026